Vitrolife AB (publ): Conference call full year report 2023
GOTHENBURG, Sweden, Jan. 24, 2024 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the fourth quarter and full year report 2023. The presentation will be held in English.
Time: Friday 2 February, 2024 at 10.00 a.m. CET.
To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group
In a demonstration of its commitment to community service, PuroClean ? one of the country's leading property restoration and remediation franchises ? marked National Superhero Day by recognizing heroes nationwide for their exceptional service and...
Done., a leader in hybrid care solutions for ADHD and other chronic psychiatric conditions, today announced that it has bolstered its pharmacy network to include partnerships with more than 30 leading pharmacies to ensure medication accessibility for...
Just days ahead of Mother's Day, we are pleased to announce a donation which will advance the health and wellbeing of women and children in our community - for generations to come. Trillium Health Partners (THP) and Trillium Health Partners...
Scout, a premier provider of clinical trial services, announced its Scout Portal platform has clinched the "Best Patient Portal" award for the second consecutive year at the 8th annual MedTech Breakthrough Awards. Hosted by MedTech Breakthrough, an...
Accushield, a leading visitor management system provider that elevates safety, security, and well-being for senior living, skilled nursing, and acute care providers, welcomes Perfect Pair, a renowned nonprofit organization dedicated to fostering...
Dyno Therapeutics today announced a collaboration with NVIDIA to leverage Dyno's field-leading artificial intelligence (AI) and in vivo experimentation capabilities, along with the built-to-scale NVIDIA BioNeMo AI-powered drug design platform, to...